African trypanosomes (Trypanosoma brucei species) are parasitic protoz
oa that cause lethal diseases in humans and cattle. Previous studies s
howed that camptothecin, a potent and specific inhibitor of DNA topois
omerase I, is cytotoxic to African trypanosomes and related pathogenic
hemoflagellates (Bodley AL and Shapiro TA, Proc Natl Acad Sci USA 92:
3726-3730, 1995). In this study, a series of camptothecin analogs was
tested against axenically cultured, bloodstream form, T. brucei. Modi
fications to the pentacyclic nucleus of camptothecin ablated antiparas
itic activity. In contrast, activity could be increased by substituent
s added to the parent ring system (e.g. 10,11-methylenedioxy or ethyle
nedioxy groups; alkyl additions to carbon 7; or g-amino or g-chloro su
bstituents), Cytotoxicity was correlated with the level of cleavable c
omplexes in trypanosomes, implicating topoisomerase I as the intracell
ular target for these compounds. To obtain some indication of selectiv
e toxicity, ten compounds were also tested against L1210 mouse leukemi
a cells. The 9-substituted-10,11-methylenedioxy analogs caused a dispr
oportionate increase in antiparasitic activity, compared with mammalia
n cell toxicity. These findings provide a basis for designing further
structural modifications and for selecting camptothecin analogs to tes
t in animal models of trypanosomiasis.